We look forward to supporting P&C Labs with long-term tools – including NovoNotifier, CytoTouch, and HL7 interfaces – that will help them continue to grow, while maintaining their focus on excellence.
PRINCETON, NJ (PRWEB) February 14, 2013
NovoPath, Inc., a leader in Anatomic Pathology (AP) Best-of-Breed Software Solutions, announces the addition of Pathology and Cytology Laboratories, Inc. to their growing list of laboratory partnerships.
Founded in 1967, P&C Labs provides the highest quality service and professional expertise to physicians, clinics, and hospitals. Based in Lexington Kentucky, their 10 board-certified pathologists offer comprehensive anatomic pathology (AP) services, as well as expert subspecialty consultations in Cytopathology (GYN and non-GYN), Hematopathology, Neuropathology, and Gastrointestinal Pathology. Their competent and caring staff is dedicated to providing highly accurate and timely patient care, and excellence in customer service for their clients.
P&C Labs currently serves a central and eastern Kentucky audience, and has a growing presence throughout the state. With a focus on incorporating innovative techniques and technologies, Charles Merritt, P&C Lab’s COO, and his team, realized their existing AP Laboratory Information System (LIS) would not keep pace with their anticipated growth. They knew their existing vendor would not continue to offer adequate support, “We knew we needed an entirely new system, and the one offered by our previous vendor did not provide the breadth of what we needed. They offered several modules through 3rd party providers, but lacked the robust cohesiveness we required.”
The lab began the evaluation process for a new Laboratory Information System at the end of 2011. It was critical that their new AP LIS fit their current needs, as well as provide them with room to grow. Initially they reviewed a handful of products, narrowing it down to four prospective vendors. The demo process further narrowed their choice to two systems that appeared to be fully integrated and would serve all their needs.
The final choice to go with NovoPath was based on looking closely at references from other labs with reliable AP professionals that had strong reputations in the field. Charles Merritt shared, “NovoPath’s track record for successful implementation far exceeded that of their competitors. We are pleased with NovoPath’s accomplishments to date – and look forward to being in a position to act as a strong reference for other labs making this decision in the future.”
Rick Callahan, VP of Sales and Marketing, shared, “We look forward to supporting P&C Labs with long-term tools – including NovoNotifier, CytoTouch, and HL7 interfaces – that will help them continue to grow, while maintaining their focus on excellence.”
About NovoPath, Inc.:
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.